{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:06:29Z","timestamp":1767852389695,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3016-y","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T14:55:33Z","timestamp":1524149733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predictive values of diagnostic codes for identifying serious hypocalcemia and dermatologic adverse events among women with postmenopausal osteoporosis in a commercial health plan database"],"prefix":"10.1186","volume":"18","author":[{"given":"Florence T.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy W.","family":"Critchlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"3016_CR1","volume-title":"Bone health and osteoporosis: a report of the surgeon general","author":"US Department of Health and Human Services","year":"2004","unstructured":"US Department of Health and Human Services. Bone health and osteoporosis: a report of the surgeon general. Rockville: US Department of Health and Human Services, Office of the Surgeon General; 2004."},{"key":"3016_CR2","first-page":"645","volume":"2","author":"EM Lewiecki","year":"2008","unstructured":"Lewiecki EM. Denosumab: an investigational drug for the management of postmenopausal osteoporosis. Biologics. 2008;2:645\u201353.","journal-title":"Biologics"},{"key":"3016_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/B978-012098655-2\/50046-6","volume-title":"The aging skeleton","author":"SE Papapoulos","year":"1999","unstructured":"Papapoulos SE. Bisphosphonates. In: Rosen CJ, Glowacki J, Bilezikian JP, editors. The aging skeleton. San Diego: Academic Press; 1999. p. 541\u20139."},{"issue":"7435","key":"3016_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/bmj.328.7435.335","volume":"328","author":"R Peter","year":"2004","unstructured":"Peter R, Mishra V, Fraser WD. Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ. 2004;328(7435):335\u20136.","journal-title":"BMJ"},{"key":"3016_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-130-4-199902160-00008","volume":"130","author":"DH Schussheim","year":"1999","unstructured":"Schussheim DH, Jacobs TP, Silverberg SJ. Hypocalcemia associated with alendronate. Ann Intern Med. 1999;130:329.","journal-title":"Ann Intern Med"},{"issue":"4 Pt","key":"3016_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0091-6749(98)70291-X","volume":"102","author":"E Phillips","year":"1998","unstructured":"Phillips E, Knowles S, Weber E, Shear NH. Skin reactions associated with bisphosphonates: a report of 3 cases and an approach to management. Allergy Clin Immunol. 1998;102(4 Pt):697\u20138.","journal-title":"Allergy Clin Immunol"},{"key":"3016_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1600-0536.2006.01071.x","volume":"57","author":"T Brinkmeier","year":"2007","unstructured":"Brinkmeier T, K\u00fcgler K, Lepoittevin JP, Frosch PJ. Adverse cutaneous drug reaction to alendronate. Contact Dermatitis. 2007;57:123\u20135.","journal-title":"Contact Dermatitis"},{"issue":"3","key":"3016_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/INF.0b013e3182421390","volume":"31","author":"J Loughlin","year":"2012","unstructured":"Loughlin J, Mast TC, Doherty MC, Wang FT, Wong J, Seeger JD. Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine. Pediatr Infect Dis J. 2012;31(3):292\u20136. https:\/\/doi.org\/10.1097\/INF.0b013e3182421390 . PMID: 22173146","journal-title":"Pediatr Infect Dis J"},{"key":"3016_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJMoa0707571","volume":"358","author":"S Schneeweiss","year":"2008","unstructured":"Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med. 2008;358:771\u201383. https:\/\/doi.org\/10.1056\/NEJMoa0707571 .","journal-title":"N Engl J Med"},{"key":"3016_CR10","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.amjcard.2010.07.041","volume":"106","author":"C Enger","year":"2010","unstructured":"Enger C, Gately R, Ming EE, Niemcryk SJ, Williams L, McAfee AT. Pharmacoepidemiology safety study of fibrate and statin concomitant therapy. Am J Cardiol. 2010;106:1594\u2013601.","journal-title":"Am J Cardiol"},{"issue":"3","key":"3016_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","volume":"110","author":"JD Seeger","year":"2007","unstructured":"Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM. Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives. Obstet Gynecol. 2007;110(3):587\u201393.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"3016_CR12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/pds.3477","volume":"22","author":"F Xue","year":"2013","unstructured":"Xue F, Ma H, Stehman-Breen C, Haller C, Katz L, et al. Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia\u00ae (denosumab) for the treatment of postmenopausal osteoporosis. Pharmacoepidemiol Drug Saf. 2013;22(10):1107\u201314.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3016_CR13","unstructured":"Centers for Medicare & Medicaid Services. Medicare claims processing manual chapter 23\u2013fee schedule administration and coding requirements. [Accessed 17 Nov 2017]. Available at: https:\/\/www.cms.gov\/Regulations-and-Guidance\/Guidance\/Manuals\/downloads\/clm104c23.pdf ."},{"key":"3016_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","volume":"22","author":"EB Wilson","year":"1927","unstructured":"Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22:209\u201312.","journal-title":"J Am Stat Assoc"},{"key":"3016_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/sim.4780100408","volume":"10","author":"BL Strom","year":"1991","unstructured":"Strom BL, Carson JL, Halpern AC, et al. Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med. 1991;10:565\u201376.","journal-title":"Stat Med"},{"issue":"1","key":"3016_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","volume":"126","author":"H-L Chan","year":"1990","unstructured":"Chan H-L, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol. 1990;126(1):43\u20137.","journal-title":"Arch Dermatol"},{"issue":"8","key":"3016_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2165\/00002018-200730080-00007","volume":"30","author":"CB Johannes","year":"2007","unstructured":"Johannes CB, Ziyadeh N, Seeger JD, Tucker E, Reiter C, Faich G. Incidence of allergic reactions associated with antibiotic use in a large managed care organization. Drug Saf. 2007;30(8):705\u201313.","journal-title":"Drug Saf"},{"key":"3016_CR18","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/pds.1214","volume":"15","author":"JD Seeger","year":"2006","unstructured":"Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf. 2006;15:784\u201392.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3016-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:36:37Z","timestamp":1604190997000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3016-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3016"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3016-y","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]},"assertion":[{"value":"5 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted using secondary data. There was no active enrollment or active follow-up of patients, and no data were directly collected from patients. The New England Institutional Review Board provided oversight during the conduct of this study and its Privacy Board granted a Waiver of Authorization for linkage of claims and medical records.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FW, DD, YD, and EN are employees of Optum Epidemiology. FX and CC are employees of Amgen, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"263"}}